Announcements Trials

Browse Landscape

Phase

Phase 2 4 Phase EARLY_PHASE1 1 Phase 1 1

Status

Recruiting 2 Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

pembrolizumab 87 Cyclophosphamide 75 Nivolumab 55 Specimen Handling 49 fludarabine 48 Magnetic Resonance Spectroscopy 44 Carboplatin 42 Biopsy 39 Radiotherapy 32 fludarabine phosphate 29 Gemcitabine 28 venetoclax 27 Paclitaxel 27 atezolizumab 26 Ipilimumab 26 Cisplatin 23 Radiation 22 Dexamethasone 22 Radiosurgery 21 durvalumab 20 Rituximab 20 Lenalidomide 19 Temozolomide 17 Bevacizumab 17 Pemetrexed 16 130-nm albumin-bound paclitaxel 16 palbociclib 15 Decitabine 15 Cytarabine 15 ibrutinib 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Active not recruiting × Losartan × Clear all

NCT04106856 2026-05-12

SHAPER

University of Utah

Phase 1 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡